| CAS Number |
Product Names |
Molecular Formula |
|
116607-29-5
|
.beta.-D-Gulopyranose, 1,6-anhydro-3-deoxy-3-nitro- SDS |
C6H9 N O6 |
|
116605-69-7
|
3-b]pyrazine SDS |
C8H6BrN3 |
|
116604-42-3
|
PEG2-bis(phosphonic acid) |
C6H16O8P2 |
|
116601-58-2
|
M-XYLENE-D10 SDS |
C8D10 |
|
116601-09-3
|
Tartaric Acid Isopropyl Ester |
C7H12O6 |
|
116599-62-3
|
O-XYLENE-ALPHA,ALPHA'-13C2 SDS |
C8H10 |
|
116599-56-5
|
1H-Imidazo[4,5-b]pyridine,5,6-dimethyl-(9CI) SDS |
C8H9N3 |
|
116599-55-4
|
Imidazo[4,5-b]pyridine, 5,7-dimethyl- (6CI,9CI) SDS |
C8H9N3 |
|
116599-52-1
|
v-Triazolo[4,5-b]pyridine-5-sulfonamide (6CI) SDS |
C5H5N5O2S |
|
116599-51-0
|
1H-1,2,3-Triazolo[4,5-c]pyridin-7-amine(9CI) SDS |
C5H5N5 |
|
116599-39-4
|
4-CHLORO-3-NITROBENZYLAMINE HYDROCHLORIDE |
C7H8Cl2N2O2 |
|
116599-11-2
|
2-Pentalenamine,octahydro-(6CI) SDS |
C8H15N |
|
116599-06-5
|
4-Ethyl-1,2-benzenediamine hydrochloride SDS |
C8H14Cl2N2 |
|
116598-94-8
|
P-XYLENE-ALPHA,ALPHA'-13C2 SDS |
C8H10 |
|
116598-88-0
|
Pyrido[3,2-d]pyrimidin-2-ol (6CI) SDS |
C7H5N3O |
|
116598-86-8
|
Pyrido[2,3-b]pyrazin-8-ol (6CI) SDS |
C7H5N3O |
|
116598-69-7
|
(6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[4,3-A]AZEPIN-3-YL)-ACETONITRILE SDS |
C9H12N4 |
|
116597-13-8
|
9-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one SDS |
C10H11N7O3 |
|
116596-29-3
|
1,1,5,5-tetranitro-(4)peristylane SDS |
C12H12N4O8 |
|
116596-20-4
|
3,5-DIBROMO-4-METHYLBENZONITRILE |
C8H5Br2N |
|
116595-05-2
|
2-Piperidinecarboxamide,3-hydroxy-(9CI) |
C6H12N2O2 |
|
116595-00-7
|
Piperazinone, 3,3-dimethyl-5-(2-methyl-2-pentenyl)- (9CI) |
C12H22N2O |
|
116591-78-7
|
2-(1,1-Diethoxyethyl)-1H-imidazole |
C9H16N2O2 |
|
116589-63-0
|
poly(propylenefumarate) methylmethacrylate SDS |
C12H20O8 |
|
116587-12-3
|
1-(N(2)-benzyloxycarbonylornithyl-gamma-glutamyl)octahydro-1H-indole-2-carboxylic acid SDS |
C27H38 N4 O8 |
|
116587-09-8
|
1-(N(2)-benzyloxycarbonyllysyl-gamma-glutamyl)octahydro-1H-indole-2-carboxylic acid SDS |
C28H40 N4 O8 |
|
116586-94-8
|
3,3,3-TRIFLUOROPROPANAL DIMETHYLACETAL SDS |
C5H9F3O2 |
|
116586-87-9
|
2H-Pyran-4-carboxylicacid,3,4-dihydro-,methylester(9CI) |
C7H10O3 |
|
116585-72-9
|
CHEMBRDG-BB 4003040 SDS |
C8H15NO |
|
116584-96-4
|
VICO 81 SDS |
C17H26N2O2 |
|
116584-95-3
|
6,9-dimethoxy-4-propyl-2,3,4a,5,10,10a-hexahydro-4H-naphtho(2,3-b)(1,4)thiazine SDS |
C17H25 N O2 S |
|
116584-94-2
|
6,9-dimethoxy-4-n-propyl-2,3,4a,5,10,10a-hexahydro-4H-naphth(2,3-b)(1,4)oxazine |
C17H25 N O3 |
|
116584-44-2
|
Isoxazole, 5-(dichlorofluoromethyl)- (9CI) SDS |
C4H2Cl2FNO |
|
116584-43-1
|
5-(TRIFLUOROMETHYL)ISOXAZOLE, 97 SDS |
C4H2F3NO |
|
116580-64-4
|
Margosan O |
|
|
116578-57-5
|
4-Pyridinepropanamine,N-methyl-(9CI) SDS |
C9H14N2 |
|
116577-83-4
|
Acetic acid, 2-(1H-benzimidazol-2-yl)hydrazide (9CI) |
C9H10N4O |
|
116577-81-2
|
3H-1,2,4-Triazolo[4,3-a]benzimidazol-3-one,1,2-dihydro-(9CI) |
C8H6N4O |
|
116577-09-4
|
(1-Amino-2-methylpropan-2-yl)(methyl)amine |
C5H14N2 |
|
116576-81-9
|
4-Pyridinecarbonyl chloride, 1,2,3,6-tetrahydro-1-methyl- (9CI) SDS |
C7H10ClNO |
|
116574-76-6
|
Pyrazino[1,2-a]azepine, 1,2,3,4,6,7,8,10a-octahydro- (9CI) |
C9H16N2 |
|
116574-75-5
|
3-FLUOROPIPERIDINE SDS |
C5H10FN |
|
116574-74-4
|
(S)-3-FLUORO-PYRROLIDINE SDS |
C4H8FN |
|
116574-72-2
|
3-(METHOXYMETHYL)PIPERIDINE SDS |
C7H15NO |
|
116574-71-1
|
N-Boc-piperidine-3-methanol SDS |
C11H21NO3 |
|
116574-14-2
|
2-Cyanoacetic acid 1-(diphenylmethyl)-3-azetidinyl ester SDS |
C19H18N2O2 |
|
116574-09-5
|
Propanoic acid, 3-amino-3-imino,1-(diphenylmethyl)-3-azetidinyl ester SDS |
C19H21N3O2 |
|
116573-93-4
|
2-Amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylic acid 3-[1-(diphenylmethyl)azetidin-3-yl]5-isopropyl ester |
|
|
116573-18-3
|
ethyl 3-[4-(6-chlorobenzooxazol-2-yl)oxyphenoxy]propanoate SDS |
C18H16ClNO5 |
|
116572-44-2
|
METHYLTRIPROPYLAMMONIUM HYDROXIDE SDS |
C10H25N1O1 |
|
116571-80-3
|
5-AMINO-15N-LEVULINIC ACID HCL SDS |
C5H10ClNO3 |
|
116571-79-0
|
2-[(13C)Isocyano]-2-methylpropane |
C5H9N |
|
116571-27-8
|
1,4-Naphthoquinone imine, 7-amino-6-chloro-5,8-dihydroxy- (6CI) |
C10H7ClN2O3 |
|
116571-26-7
|
Juglone, 3,8-diamino-2-chloro- (6CI) SDS |
C10H7ClN2O3 |
|
116570-74-2
|
PYRAZOLE-3-CARBONYL AZIDE SDS |
C4H3N5O |
|
116570-49-1
|
3-CHLORO-6-HYDROXY (1H)INDAZOLE SDS |
C7H5ClN2O |
|
116570-41-3
|
5,7-DIFLUORO ISATIN SDS |
C8H3F2NO2 |
|
116570-12-8
|
2-(1H-TETRAZOL-1-YL)BENZOIC ACID SDS |
C8H6N4O2 |
|
116569-31-4
|
Benzoic acid, 2-hydroxy-5-isothiocyanato- (9CI) SDS |
C8H5NO3S |
|
116569-09-6
|
5-HYDROXY ISATIN SDS |
C8H5NO3 |
|
116569-08-5
|
6-HYDROXY-INDOLE-2,3-DIONE SDS |
C8H5NO3 |
|
116569-07-4
|
1H-Indole-2,3-dione,7-hydroxy-(9CI) SDS |
C8H5NO3 |
|
116569-00-7
|
3-(Methoxycarbonyl)cyclobutanecarboxylicacid |
C7H10O4 |
|
116568-17-3
|
1H-BENZIMIDAZOLE-5-CARBOXAMIDE SDS |
C8H7N3O |
|
116567-17-0
|
N-(3-BROMOPHENYL)HYDRAZINECARBOTHIOAMIDE SDS |
C7H8BrN3S |
|
116565-92-5
|
[1,4]Dioxino[2,3-g]benzothiazole(9CI) SDS |
C9H5NO2S |
|
116565-74-3
|
Chromium lead oxide sulfate, silica-modified |
|
|
116565-73-2
|
CHROMIUM LEAD MOLYBDENUM OXIDE SULFATE, SILICA-MODIFIED) |
|
|
116565-72-1
|
Benzene, diethenyl-, polymer with ethenylbenzene and ethenylethylbenzene, chloromethylated, N,N-dibutyl-1-butanamine-quaternized |
|
| MW: |
|
116564-73-9
|
11-Methoxy-7-methyl-1,2,3,10,11,11a-hexahydro-5H-pyrrolo(2,1-c)(1,4)be nzodiazepin-5-one SDS |
C14H18N2O2 |
|
116561-26-3
|
1,3-Dioxolane-4-carbonyl chloride, 2,2-dimethyl-, (4S)- (9CI) SDS |
C6H9ClO3 |
|
116560-97-5
|
4-[[(1S)-1-[[(2S)-2-[[(2S)-2-[(1-carboxy-3-phenyl-propyl)amino]propano yl]amino]propanoyl]carbamoyl]-2-phenyl-ethyl]amino]benzoic acid SDS |
C32H36N4O7 |
|
116557-46-1
|
2-amino-6-bromoanisole SDS |
C7H8BrNO |
|
116557-07-4
|
ethyl 5-chloroquinoline-4-carboxylate SDS |
C12H10ClNO2 |
|
116549-74-7
|
antithrombin III Northwick Park |
|
|
116549-34-9
|
3,3-DIMETHOXYHEXANE SDS |
C8H18O2 |
|
116549-11-2
|
5-CHLORO-6-NITRO-1,3-BENZOXAZOLE |
C7H3ClN2O3 |
|
116548-70-0
|
Benzoic acid, 5-(ethylamino)-2-nitroso- (9CI) |
C9H10N2O3 |
|
116548-39-1
|
Methanol, [3-(6-methoxy-3-pyridinyl)-1-methyl-2-triazenyl]- (9CI) |
C8H12N4O2 |
|
116548-08-4
|
2-HYDROXY-4-METHYL-6-TRIFLUOROMETHYL-NICOTINNITRILE SDS |
C8H5F3N2O |
|
116548-07-3
|
2-Hydroxy-4-methyl-6-(trifluoromethyl)nicotinamide SDS |
C8H7F3N2O2 |
|
116548-04-0
|
3-Cyano-6-(trifluoromethyl)pyrid-2-one SDS |
C7H3F3N2O |
|
116548-03-9
|
2-Hydroxy-6-(trifluoromethyl)nicotinamide SDS |
C7H5F3N2O2 |
|
116548-02-8
|
1,2-Dihydro-2-oxo-6-(trifluoromethyl)-3-pyridinecarboxylic acid ethyl ester SDS |
C9H8F3NO3 |
|
116547-91-2
|
N-(2-Bromophenyl)methansulfonamide SDS |
C7H8BrNO2S |
|
116546-99-7
|
Cyclobutanecarboxylic acid, 1-cyano-3-methylene-, methyl ester (9CI) |
C8H9NO2 |
|
116546-14-6
|
Allyl alcohol-2-13C |
C3H6O |
|
116546-04-4
|
3-DIMETHYLAMINOMETHYL-4-HYDROXY-BENZALDEHYDE SDS |
C10H13NO2 |
|
116545-23-4
|
1H-Pyrazol-3-amine, 4-chloro-N-ethyl-5-methyl- SDS |
C6H10ClN3 |
|
116545-20-1
|
1H-Pyrazol-3-amine,N-ethyl-5-methyl-(9CI) SDS |
C6H11N3 |
|
116545-19-8
|
1H-Pyrazol-3-amine, N-(1,1-dimethylethyl)-5-methyl- SDS |
C8H15N3 |
|
116545-16-5
|
4-Isoxazolecarboxylicacid,3-(ethylamino)-5-methyl-,ethylester(9CI) SDS |
C9H14N2O3 |
|
116545-14-3
|
3-Isoxazolamine,4-chloro-N-ethyl-5-methyl-(9CI) SDS |
C6H9ClN2O |
|
116545-04-1
|
2-BROMO-3-(1-NAPHTHYL)-1-PROPENE SDS |
C13H11Br |
|
116543-92-1
|
METHYL 6-BROMO-4-OXO-4H-CHROMENE-2-CARBOXYLATE |
C11H7BrO4 |
|
116543-91-0
|
Methyl 6-fluorochroMone-2-carboxylate |
C11H7FO4 |
|
116540-88-6
|
3-CHLORO-6,6A-DIHYDRO-1AH-1-OXA-CYCLOPROPA[A]INDENE SDS |
C9H7ClO |
|
116539-70-9
|
3-DIAZO-N-NITROSOBAMETHAN |
C12H16N4O3 |
|
116539-60-7
|
(R)-Duloxetine SDS |
C18H19NOS.ClH |
|
116539-59-4
|
Duloxetine SDS |
C18H19NOS |
